Therapy Areas: Cardiovascular
Organon signs commercialisation agreement for Nilemdo across six European markets
8 January 2026 - US healthcare company Organon (NYSE:OGN) announced on Thursday that it has entered into a commercialisation agreement with Daiichi Sankyo Europe to distribute and promote Nilemdo in F...
Antin to acquire clinical trial equipment provider Emsere
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emse...
GSK wins European Commission approval for Shingrix prefilled syringe
7 January 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Wednesday that the European Commission has approved a prefilled syringe presentation of its shingles vaccine Shin...
Tri-City Cardiology adds new members to care team
29 December 2025 - Tri-City Cardiology, a Phoenix, Arizona-based cardiology group, announced on Friday that it has added Dr. Olubadewa A. Fatunde and Dr. Umashankar Lakshmanadoss to its care team.Dr. ...
Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration
24 December 2025 - Pharmaceutical companies Italfarmaco S.p.A. and JCR Pharmaceuticals Co, Ltd (TSE 4552) on Wednesday announced an exclusive licensing agreement granting JCR Pharmaceuticals rights to...
GENinCode expands Mexico presence with CARDIO inCode-Score distribution agreement
17 December 2025 - Oxford based predictive genetics company GENinCode Plc (AIM: GENI) revealed on Wednesday that it has entered into a commercial distribution agreement with Sohin Genetics to market C...